Get notified when JNJ files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsJ&J proposes $5.5B settlement to resolve 76,000 ovarian talc claims, requires 95% participation
Filed July 28, 2026 · Period ending July 27, 2026 · ~1 min read
Key Changes
-
high
J&J commits $5.5B to settle remaining ovarian talc litigation covering ~76,000 claims, with first payment of up to $3B in 2027 and no further payments before 2028, contingent on 95% plaintiff participation.
Exhibit 99.1 view on EDGAR → -
high
MDL court on July 22, 2026 ordered plaintiffs to justify why claims should not be dismissed for inability to prove specific causation, after plaintiffs withdrew experts in two bellwether cases following hearing that exposed methodological flaws.
Exhibit 99.1 view on EDGAR → -
medium
Settlement would complete talc litigation resolution after J&J previously settled ~95% of mesothelioma lawsuits, all state consumer protection claims, and all talc-supplier disputes.
Exhibit 99.1 view on EDGAR →
1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (IMMR 10-K) is open in full — no account needed.
Partner
Trade JNJ commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jul 29, 2026 · How we verify